Amanda Feilding is Director of the Beckley Foundation, a UK-based think tank and UN-accredited NGO, which she founded in 1998. Its chief objectives are studying the mechanisms underlying altered states of consciousness and reforming global drug policy. She is dubbed the ‘hidden hand behind the renaissance of psychedelic science and drug policy reform.”
Through the Scientific Programme, Amanda orchestrates collaborations with leading scientists worldwide, investigating cannabis, psilocybin, LSD, Ayahuasca, DMT and MDMA. These include clinical trials identifying the effects of psychoactive substances on cerebral circulation, brain function, subjective experience, and clinical symptoms. She co-directs the thriving Beckley/Imperial Research Programme with Prof David Nutt.
Through the Policy Programme, Amanda advocates policy-making informed by scientific evidence. She has established a seminar series, Drugs & Society: A Rational Perspective, producing over 40 books and policy reports. Amanda advises world leaders on policy reform– most recently the Jamaican government on forming their cannabis industry.